WhyOSA

Company Overview

Snapshot

Founded in March 2026 by Ran Manevich and Shahar Levi, WhyOSA operates with 1–10 employees. The company secured its Seed funding round in March 2026, with participation from ICI Fund.

Business overview

WhyOSA develops a clinical decision-support platform for obstructive sleep apnea (OSA). This solution integrates patient data, clinical evidence, and AI models to assist physicians in identifying the most suitable treatment for each patient, thereby reducing trial-and-error in therapy selection. The platform aims to enhance patient outcomes, improve therapy adherence, and streamline clinical workflows for sleep medicine providers and healthcare organizations within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices.

Company Intelligence Q&A

When was WhyOSA founded?

WhyOSA was founded in March 2026.

Who are the founders of WhyOSA?

WhyOSA was founded by Ran Manevich and Shahar Levi.

What is WhyOSA's primary sector?

WhyOSA's primary sector is Health Tech & Life Sciences, with a focus on Medical Devices.

What is the core product of WhyOSA?

WhyOSA develops an AI-powered clinical decision-support platform designed to match sleep apnea patients to the most appropriate treatment by integrating patient data, clinical evidence, and AI models.

When did WhyOSA receive its Seed funding?

WhyOSA received Seed funding in March 2026.